Latest News and Press Releases
Want to stay updated on the latest news?
-
Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; April 14, 2026 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital...
-
VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) -- Eldorado Gold Corporation (TSX:ELD) (NYSE:EGO) (“Eldorado”) is pleased to announce the completion of Eldorado’s acquisition of all of...
-
LAVAL, Québec, 14 avr. 2026 (GLOBE NEWSWIRE) -- Corporation Savaria (« Savaria ») (TSX : SIS), l’un des chefs de file mondiaux de l’industrie de l’accessibilité, a le plaisir de tenir sa...
-
There are 2 press releases, English and French, that need to be published on April 14, 2026 at 7:30 am.
-
AUSTIN, Texas and NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) today announced a proposed underwritten public offering of $125.0...
-
I henhold til Lov om kapitalmarkeder § 30 skal Solar A/S hermed meddele, at UBS Group AG i dag har meddelt Solar, at efter køb af aktier den 10. april 2026 har UBS Group AG en beholdning på 401.630...
-
Pursuant to section 30 of the Danish Capital Markets Act, Solar A/S hereby announces that UBS Group AG today has informed Solar that following its purchase of shares on 10 April 2026, UBS Group AG’s...
-
• VB4-P5 – novel new chemical entity with potential to address significant unmet need in rare and large-market chronic kidney disease • CALGARY, Alberta, April 13, 2026 (GLOBE NEWSWIRE) -- XORTX...
-
Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today...
-
REDWOOD CITY, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed...